Pharmacologic management of osteoarthritis-related pain in older adults: A review shows that many drug therapies provide small-to-modest pain relief

Orthopaedic Nursing

Volumn 31, Issue 2, 2012, Pages 109-114

  Reid, M Carrington ^a   Shengelia, Rouzi ^b   Parker, Samantha J ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WCMC ^*  (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia; older adults; osteoarthritis; pain

Indexed keywords

EID: 84859146233     PISSN: 07446020     EISSN: 1542538X     Source Type: Journal    
DOI: 10.1097/NOR.0b013e31824fce26     Document Type: Review

References (60)

1. Centers for Disease Control and Prevention (CDC). Prevalence of disabilities and associated health conditions among adults-United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50(7):120-5.
2. Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritisattributable activity limitation-United States, 2003- 2005. MMWR Morb Mortal Wkly Rep 2006;55(40): 1089-92.
3. Dillon CF, et al. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol 2006;33(11):2271-9. (Pubitemid 44749788)
4. Qvist P, et al. The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon? Pharmacol Res 2008 58 1 1-7.
5. Sarzi-Puttini P, et al. Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum 2005;35(1 Suppl 1):1-10. (Pubitemid 41097249)
6. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43(9):1905-15.
7. Austrian JS, et al. Perceived barriers to trying selfmanagement approaches for chronic pain in older persons. J Am Geriatr Soc 2005;53(5):856-61. (Pubitemid 41656933)
8. Sarzi-Puttini P, et al. Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experience. Semin Arthritis Rheum 2005;35(1 Suppl 1): 38-42. (Pubitemid 41097254)
9. Barry LC, et al. Identifi cation of pain-reduction strategies used by community-dwelling older persons. J Gerontol A Biol Sci Med Sci 2005;60(12):1569-75. (Pubitemid 43146464)
10. Jordan KM, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62(12):1145-55. (Pubitemid 37500619)
11. Ibrahim SA. Racial variations in the utilization of knee and hip joint replacement: an introduction and review of the most recent literature. Curr Orthop Pract 2010;21(2):126-31.
12. AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002;50(6 Suppl):S205-S224.
13. AGS Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57(8):1331-46.
14. Leveille SG, et al. Disabling symptoms: what do older women report? J Gen Intern Med 2002 17 10 766-73 (Pubitemid 35286242)
15. Reid MC, et al. Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Med 2011;12(9):1336-57.
16. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ Lawrence Erlbaum Associates, Inc.; 1988.
17. Towheed TE, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006(1):CD004257.
18. Zhang W, et al. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 2004;63(8): 901-7. (Pubitemid 38961912)
19. Larson AM, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42(6):1364-72. (Pubitemid 43260039)
20. Rahme E, et al. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 2008;103(4):872-82. (Pubitemid 351501121)
21. U.S. Food and Drug Administration. Drugs: acetaminophen information 2011. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm165107. htm.
22. Laine L. Approaches to nonsteroidal anti-infl ammatory drug use in the high-risk patient. Gastroenterology 2001;120(3):594-606. (Pubitemid 32171634)
23. Talley NJ, et al. Nonsteroidal antiinfl ammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995;40(6): 1345-50.
24. Bjordal JM, et al. Non-steroidal anti-infl ammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 2004;329(7478):1317.
25. Trelle S, et al. Cardiovascular safety of non-steroidal anti-infl ammatory drugs: network meta-analysis. BMJ 2011;342:c7086.
26. Perez Gutthann S, et al. Nonsteroidal anti-infl ammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 1996;156(21):2433-9.
27. Wolfe MM, et al. Gastrointestinal toxicity of nonsteroidal antiinfl ammatory drugs. N Engl J Med 1999; 340(24):1888-99. (Pubitemid 29272670)
28. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000;160(6):777-84. (Pubitemid 30165238)
29. Nüesch E, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009(4):CD003115.
30. Papaleontiou M, et al. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2010;58(7):1353-69.
31. Solomon DH, et al. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010;170(22):1968-76.
32. Spitz A, et al. Primary care providers' perspective on prescribing opioids to older adults with chronic noncancer pain: a qualitative study. BMC Geriatr 2011; 11:35.
33. Towheed TE, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2001(1): CD002946.
34. Black C, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess 2009;13(52):1-148.
35. Reichenbach S, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 2007;146(8):580-90. (Pubitemid 351650539)
36. Poolsup N, et al. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann Pharmacother 2005;39(6):1080-7. (Pubitemid 40695976)
37. Taylor RS, et al. Safety profi le of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions. Curr Med Res Opin 2011;27(3):605-22.
38. Haroutiunian S, et al. Topical NSAID therapy for musculoskeletal pain. Pain Med 2010;11(4):535-49.
39. Lin J, et al. Effi cacy of topical non-steroidal antiinfl ammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004;329(7461):324.
40. Baraf HS, et al. Safety and effi cacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. Drugs Aging 2011;28(1): 27-40.
41. Altman RD. New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm. Curr Med Res Opin 2010;26(12):2871-6.
42. Makris UE, et al. Adverse effects of topical nonsteroidal antiinfl ammatory drugs in older adults with osteoarthritis: a systematic literature review. J Rheumatol 2010;37(6):1236-43.
43. Kivitz A, et al. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Clin Ther 2008;30(12):2366-77.
44. Galer BS, et al. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Curr Med Res Opin 2004;20(9):1455-8. (Pubitemid 39361349)
45. Gammaitoni AR, et al. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin 2004;20 Suppl 2:S13-S19. (Pubitemid 40179646)
46. Mason L, et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004;328(7446): 991.
47. Kosuwon W, et al. Effi cacy of symptomatic control of knee osteoarthritis with 0.0125% of capsaicin versus placebo. J Med Assoc Thai 2010;93(10):1188-95.
48. Bellamy N, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006(2):CD005328.
49. Heyworth BE, et al. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial. J Hand Surg Am 2008;33(1):40-8. (Pubitemid 351186831)
50. Atchia I, et al. Effi cacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis 2011;70(1):110-6.
51. Shimizu M, et al. Clinical and biochemical characteristics after intra-articular injection for the treatment of osteoarthritis of the knee: prospective randomized study of sodium hyaluronate and corticosteroid. J Orthop Sci 2010;15(1):51-6.
52. Chevalier X, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis 2010;69(1):113-9.
53. Clarke S, et al. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK). Knee 2005;12(1):57-62. (Pubitemid 40128161)
54. Bellamy N, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005(2):CD005321.
55. Bourgeois FT, et al. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010;153(3):158-66.
56. Green CR, et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med 2003;4(3):277-94.
57. Committee on Advancing Pain Research, Care, and Education, Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press 2011 http//www.nap.edu/catalog. php?record-id=13172
58. MUST for Seniors. Medication use safety training for seniors [landing page]. National Council on Patient Information and Education. 2011. http://www. mustforseniors.org.
59. Hall J, et al. Effectiveness of interventions designed to promote patient involvement to enhance safety: a systematic review. Qual Saf Health Care 2010; 19(5):e10.
60. Paparella SF, et al. Patient safety simulation: learning about safety never seemed more fun. J Nurses Staff Dev 2004;20(6):247-52.